0001144204-19-033813.txt : 20190703
0001144204-19-033813.hdr.sgml : 20190703
20190703170041
ACCESSION NUMBER: 0001144204-19-033813
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190703
DATE AS OF CHANGE: 20190703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bright Lisa
CENTRAL INDEX KEY: 0001635111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 19942485
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET, SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 10 HUDSON YARDS, 37TH FLOOR
CITY: New York
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tv524732_form4.xml
FORM 4
X0306
4
2019-07-01
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001635111
Bright Lisa
C/O INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, FLOOR 37
NEW YORK
NY
10001
0
1
0
0
President, International
Common Stock
2019-07-01
4
F
0
530
79.17
D
20452
D
Common Stock
2019-07-03
4
S
0
595
78.66
D
19857
D
Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock awards previously granted to the reporting person.
This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Mark Pruzanski, as attorney-in-fact
2019-07-03